Ketamine produces a dreamlike, floating state where you feel detached from your body and surroundings. At the low doses used in therapy for depression, people commonly describe feeling “spacey,” “loopy,” or like they’re gently melting into their environment. At higher doses, the experience intensifies into vivid visual hallucinations, a warped sense of time, and a complete separation from your physical self. The specific effects depend heavily on dose, and the gap between a therapeutic session and full anesthesia is significant.
How the Low Therapeutic Dose Feels
The standard dose used to treat depression is 0.5 mg/kg delivered intravenously over 40 minutes. That’s roughly a quarter of what’s needed for surgical anesthesia, so the experience is much milder than what the drug was originally designed to do. When ketamine was first tested in the 1960s, people at this level described feeling “spaced out” or like they were dreaming while still awake.
Modern patients receiving ketamine for depression report a cluster of sensations that researchers group under the term “dissociation.” In plain terms, this means a sense of detachment, both from your own body and from the room around you. You might feel like you’re floating, like the edges of objects are softening, or like time is stretching and compressing unpredictably. Some people feel giddy or giggly. Others describe a deep peacefulness that’s hard to put into words. A sense of disinhibition is common, similar to the looseness you might feel after a couple of drinks, though the quality of the experience is very different from alcohol.
Sensory perception shifts noticeably. Sounds may seem distant or echoey. Your body can feel unusually heavy or weightless. Some people see colors more vividly or notice gentle visual distortions, like surfaces appearing to breathe or ripple. These effects aren’t universal, and their intensity varies from person to person and session to session.
The Timeline From Start to Finish
When ketamine is given intravenously, the effects begin within about 45 to 60 seconds. The dissociative sensations typically build over the first 10 to 15 minutes of a 40-minute infusion, peak somewhere around the midpoint or shortly after, and then gradually fade once the drip stops. Most of the noticeable mental effects clear within 15 to 20 minutes after the infusion ends, though you’ll likely feel foggy and a bit off-balance for a while longer.
When given as a muscle injection, onset takes 3 to 8 minutes and the effects last longer, roughly 45 minutes to over an hour. The nasal spray version (esketamine, sold as Spravato) falls somewhere in between. Regardless of the method, the acute experience is relatively brief compared to other psychoactive substances.
What a Higher Dose Feels Like
Recreational users and people receiving higher clinical doses describe a much more intense version of the same dissociative spectrum. The most well-known phenomenon is the “K-hole,” a state that occurs at doses approaching anesthetic levels (roughly 1 to 2 mg/kg intravenously). In a study of recreational users, two-thirds said the most compelling aspects of ketamine were “melting into the surroundings,” vivid visual hallucinations, and out-of-body experiences.
In a K-hole, people report feeling completely separated from their physical body, sometimes perceiving themselves from above or from across the room. The sense of self can dissolve entirely. Some describe traveling through tunnels or vast spaces, encountering geometric patterns, or losing all awareness that they have a body at all. This state can feel profoundly meaningful to some people and terrifying to others. At full anesthetic doses (2 mg/kg IV and above), consciousness fades entirely.
The Less Pleasant Side Effects
Not everything about the experience is ethereal. Nausea is one of the most commonly reported side effects, and it can hit during or shortly after a session. Some people experience headaches or a spike in anxiety, particularly during the onset phase when the dissociation is ramping up and the sensation is unfamiliar.
Blood pressure rises temporarily in a significant number of people. Studies report transient increases in 10 to 50 percent of patients during infusion, and roughly 20 to 30 percent may see readings climb above 180/100, though this is usually brief. About 12.5 percent of patients in one large study experienced what clinicians would classify as severe hypertension, with the first few sessions carrying the highest risk. Heart rate can also increase. These cardiovascular effects are the main reason clinics monitor you throughout the process.
Dizziness and difficulty speaking clearly are common during the infusion itself. Some people find the dissociation unpleasant rather than peaceful, describing it as disorienting or unsettling. The experience tends to become more predictable and less alarming with repeated sessions.
What a Clinical Session Looks Like
If you’re receiving ketamine for depression, the setting is designed to keep you comfortable and safe during the altered state. You’ll typically recline in a chair or on a bed in a dimly lit room. Many clinics offer an eye mask to block visual stimulation and headphones playing calm music, often classical. Some programs incorporate brief mindfulness prompts between musical tracks to help you stay grounded and turn your attention inward. A staff member stays nearby throughout.
For Spravato (the FDA-approved nasal spray), you self-administer the spray under direct supervision in a clinic. The spray comes in devices that each deliver 28 mg, and a typical dose requires two or three devices used five minutes apart. After administration, you’re monitored for at least two hours before a clinician assesses whether you’re stable enough to leave. You cannot drive yourself home. FDA guidelines prohibit driving or operating machinery until the next day, after a full night of sleep. Clinics also recommend keeping the rest of your treatment day free of anything demanding: no work presentations, exams, or major decisions.
Why It Affects the Brain So Quickly
Most antidepressants take weeks to produce noticeable changes. Ketamine can shift mood within hours. The reason comes down to how differently it works in the brain. Traditional antidepressants adjust serotonin levels. Ketamine blocks a specific type of receptor involved in glutamate signaling, which is the brain’s primary excitatory chemical messenger. By blocking these receptors, ketamine paradoxically triggers a surge of glutamate activity, particularly in the prefrontal cortex, the area involved in mood regulation, decision-making, and emotional processing.
This burst of activity appears to kick-start the growth of new synaptic connections between brain cells. Animal research has shown that a single dose of ketamine increases the number of synapses in mood-related brain regions within 24 hours and also promotes the growth of tiny blood vessels that support those new connections. This rapid rewiring is thought to explain why people can feel a meaningful lift in depression symptoms so quickly, sometimes within a single day of treatment. The antidepressant effect from a single infusion typically lasts days to about a week, which is why treatment protocols involve repeated sessions.
FDA-Approved Uses
Esketamine nasal spray (Spravato) is currently FDA-approved for two specific situations: treatment-resistant depression in adults, meaning depression that hasn’t responded to at least two other medications, and depressive symptoms in adults with major depressive disorder who are experiencing acute suicidal thoughts or behavior. In both cases, it’s prescribed alongside an oral antidepressant rather than as a standalone treatment. It’s available only through a restricted program that requires administration in a certified healthcare setting with mandatory post-dose monitoring.
Standard intravenous ketamine for depression is used off-label at clinics across the country. The typical protocol involves a series of six infusions over two to three weeks at the 0.5 mg/kg dose, followed by maintenance sessions spaced further apart. Because this use isn’t FDA-approved, insurance coverage varies widely, and many patients pay out of pocket.